Showing results (1001-1010 of 1,116) with videos related to

Sort By:
Pageof 112
Gastroenterology|May 7, 2020
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated DiseasesEli Stahl, Giulia Roda, Amanda Dobbyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoireEvan R Abt, Alex K Lam, Miyako Noguchi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Frontiers in Neuroscience|September 17, 2021
Oscillatory Pattern of Sympathetic Nerve Bursts Is Associated With Baroreflex Function in Heart Failure Patients With Reduced Ejection FractionEdgar Toschi-Dias, Nicola Montano, Eleonora Tobaldini, et al.
Trials|March 27, 2024
Implementing and evaluating group interpersonal therapy for postnatal depression in Lebanon and Kenya-individually randomised superiority trialPeter Fonagy, Rabih El Chammay, Carol Ngunu, et al.
Circulation. Heart Failure|January 11, 2011
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trialDavid A Baran, Mark J Zucker, Luis H Arroyo, et al.
Science Translational Medicine|October 26, 2018
<i>Clostridioides difficile</i> uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrheaEric J Battaglioli, Vanessa L Hale, Jun Chen, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticlesZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2021
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)Hamideh Parhiz, Jacob S Brenner, Priyal N Patel, et al.
Crohn'S & Colitis 360|February 13, 2023
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center ExperienceGuilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, et al.
Pageof 112